Cargando…
Impact of prescription size on statin adherence and cholesterol levels
BACKGROUND: Therapy with 3-Hydroxy-3-methylglutaryl Co-enzyme A reductase inhibitors (statins) improve outcomes in a broad spectrum of patients with hyperlipidemia. However, effective therapy requires ongoing medication adherence; restrictive pharmacy policies may represent a barrier to successful a...
Autores principales: | Batal, Holly A, Krantz, Mori J, Dale, Rita A, Mehler, Phillip S, Steiner, John F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174936/ https://www.ncbi.nlm.nih.gov/pubmed/17961256 http://dx.doi.org/10.1186/1472-6963-7-175 |
Ejemplares similares
-
Access and care issues in urban urgent care clinic patients
por: Scott, David R, et al.
Publicado: (2009) -
Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study
por: Svensson, Elisabeth, et al.
Publicado: (2015) -
Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
por: Li, Josephine H., et al.
Publicado: (2014) -
Decreasing cholesterol levels in the community – lifestyle change with statin?
por: Savolainen, Jorma, et al.
Publicado: (2015) -
Resting tachycardia, a warning sign in anorexia nervosa: case report
por: Krantz, Mori J, et al.
Publicado: (2004)